Glycine

Glycine

SCHEMBL8830879

NC(=O)N1CCCC1.NCC(=O)O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLRA1 P23415 1/20 0.48
SLC6A9 P48067 1/20 0.48
OR51E2 Q9H255 1/20 0.48
HTT P42858 1/20 0.39
ATM Q13315 1/20 0.39
DPP7 Q9UHL4 1/20 0.39
ALDH1A1 P00352 4/20 0.39
F2 P00734 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP1A2 P05177 1/20 0.34
MAPK1 P28482 1/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 1/20 0.34
HPGD P15428 2/20 0.33
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP3 P08254 1/20 0.33
MMP9 P14780 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycine SCHEMBL8830859 0.98 GLRA1 (0.46) GLRA1SLC6A9OR51E2HTTATM
Succinic Acid SCHEMBL5403541 0.86 ATM (0.44) HTTATMDPP7ALDH1A1F2
Beta-Alanine SCHEMBL9092097 0.85 ATM (0.40) HTTATMDPP7ALDH1A1SMN1; SMN2
SCHEMBL1363715 0.84
SCHEMBL302276 0.84
Succinic Acid SCHEMBL5411814 0.84 SMN1; SMN2 (0.47) HTTATMDPP7ALDH1A1F2
Beta-Alanine SCHEMBL27722682 0.83 CYP1A2 (0.42) HTTATMDPP7ALDH1A1F2
SCHEMBL23963672 0.82 ALDH1A1 (0.55) HTTATMDPP7ALDH1A1F2
SCHEMBL2281541 0.82
SCHEMBL7749269 0.82 ALDH1A1 (0.55) HTTATMDPP7ALDH1A1F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997011080-A1 SUBSTITUTED THIOL MACROLACTAM IMMUNOMODULATORS ABBOTT LABORATORIES (US) 1997-03-27 WO disclosed
US-5604234-A IMMUNOSUPPRESSANTS; TREATING AUTOIMMUNE DISEASES, TRANSPLANT REJECTION ABBOTT LABORATORIES (US) 1997-02-18 US disclosed